Building on a decade of success, IV is pleased to announce that Global Good projects have transitioned to the Bill & Melinda Gates Foundation and Gates Ventures.

GHT team to focus on inventing technology to improve the health of those who need it most.

Algorithm could revolutionize cervical cancer screening, especially in low-resource settings.

Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.

IV research scientist Corrie Ortega shares her background and what her experience at IV has been like in this Seattle Times Q&A.